1

Center for Computational Molecular Phenotyping

• Principal Investigator: Robert E. Marc, PI• Computational Molecular Phenotyping (CMP) is a set of

technologies to visualize small molecules in cells• Small molecules form the cellular “metabolome” and

“metabolomics” is the next frontier in molecular medicine• The Marc Laboratory possesses a large library of probes• The Marc Laboratory has three key technologies for commercialization:

(1) CMP probe reagents to track small molecules(2) CMP microscope platforms to image molecules(3) CMP software for analyze molecular fingerprints

• Potential IP includes probes applications,CMP platform component technologies, software applications, testing kits, and CMP systems for: medical diagnostics,drug discovery, forensics, environmental testing and agronomics screening.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

2

Center for Computational Molecular Phenotyping

• MARKET OVERVIEW– Key small-scale large-scale market & employment opportunities

1-2 y : Neuroscience Research “Niche” $1.75 M/annum2-3 y : Cell Biology Research $2-10 M/annum4+ y : Medical diagnostics $10M-20 B/annum

– Leading long-term market targetsChronic disease risk screeningOncology screening tools: molecular fingerprinting systemsNutrition monitoringDrug Discovery

– Current distributors & licenseesSignature Immunologics (licensee and probe development)Chemicon, AbCAM, Cosmobio (distributors)

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.